Intragastric balloon in ethnic obese Chinese: Initial experience

Obesity Surgery

Volumn 16, Issue 3, 2006, Pages 308-313

  Mui, Wilfred Lik Man ^a   So, Wing Yee ^a   Yau, Phyllis Yin Ping ^a   Lam, Chuen Hing ^a   Yung, Man Yee ^a   Cheng, Angela Yuen Shan ^a   Chow, Francis Chun Chung ^a   Ng, Enders Kwok Wai ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Intragastric balloon; Non surgical treatment; Obesity

Indexed keywords

DIAZEPAM; ONDANSETRON; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; BALLOON; BODY MASS; BODY WEIGHT; CHINESE; CLINICAL ARTICLE; DEVICE; ETHNOLOGY; EXPERIENCE; FEMALE; HUMAN; LENGTH OF STAY; MALE; MINIMALLY INVASIVE SURGERY; OBESITY; OPERATION DURATION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE NAUSEA; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; SAFETY; STOMACH EROSION; STOMACH ULCER; TREATMENT OUTCOME; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ADULT; BARIATRIC SURGERY; BODY MASS INDEX; CHINA; FEMALE; GASTRIC BALLOON; HONG KONG; HUMANS; MALE; MIDDLE AGED; OBESITY, MORBID; PROSPECTIVE STUDIES;

EID: 33645309875     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1381/096089206776116516     Document Type: Article

References (22)

1. Health implications of obesity. National Institutes of Health Consensus Development Conference Statement. Ann Intern Med 1985; 103: 1073-7.
2. Calle EE, Thun MJ, Petrelli JM et al: Body-mass index and mortality in a prospective cohort of U.S. adults. N Eng J Med 1999; 341: 1097-105.
3. Ko GT, Wu MM, Tang J et al. Body mass index profile in Hong Kong Chinese adults. Ann Acad Med Singapore 2001; 30: 393-6.
4. Lee WJ, Wang W. Bariatric surgery: Asia-Pacific perspective. Obes Surg 2005; 15: 751-7.
5. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. WHO/NUT/NCD/98.1. WHO Technical Support Series, WHO, Geneva, 1989: p. 1-276.
6. Brownell KD, Rodin J. Medical, metabolic, and psychological effects of weight cycling. Arch Intern Med 1994; 154: 1325-30.
7. Christou NV, Sampalis JS, Liberman M et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004; 240: 416-24.
8. Sagar PM. Surgical treatment of morbid obesity. Br J Surg 1995; 82: 732-9.
9. Totte E, Hendrickx L, Pauwels M et al. Weight reduction by means of intragastric device: experience with Bioenterics Intragastric Balloon. Obes Surg 2001; 11: 519-23.
10. Doldi SB, Micheletto G, Perrini MN et al. Treatment of morbid obesity with intragastric balloon in association with diet. Obes Surg 2002; 12: 583-7.
11. Loffredo A, Cappuccio M, De Luca et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg 2001; 11: 330-3.
12. Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon free follow-up. Gastrointest Endosc 2005; 61: 19-27.
13. Evans JD, Scott MH. Intragastric balloon in the treatment of patients with morbid obesity. Br J Surg 2001; 88: 1245-8.
14. Sallet JA, Marchesini JB, Paiva DS et al. Brazilian multicenter study of intragastric balloon. Obes Surg 2004; 14: 991-8.
15. Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six year study in 2,410 patients. Obes Surg 2005; 15: 1304-8.
16. Nieben OG, Harboe H. Intragastric balloon as an artificial bezoar for treatment of obesity. Lancet 1982; 1: 189-9.
17. Ulicny KS Jr, Goldberg SJ, Harper WJ et al. Surgical complications of Garren-Edwards Gastric Bubble. Surg Gynecol Obstet 1988; 166: 535-40.
18. Boyle TM, Angus SG, Bauer JJ et al. Small intestinal obstruction secondary to obturation by a Garren gastric bubble. Am J Gastroenterol 1987; 82: 51-3.
19. Marshell JB, Schreiber H, Kolozsi W et al. A prospective multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. Am J Gastroenterol 1990; 85: 833-7.
20. Bioenterics Intragastric Balloon (BIB®) System. Revision to Indications for use. Manufacturer's guidelines information sheet. Carpinteria, CA: Bioenterics Corporation, 1999.
21. Hervé J, Wahlen CH, Schaeken A et al. What becomes of patients one year after the intragastric balloon has been removed? Obes Surg 2005; 15: 864-70.
22. Mckeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991; 337: 382-6.